Bezalip Bezafibrato medication

Bezalip, containing the active ingredient Bezafibrate, is a medication primarily used to manage high levels of lipids, such as cholesterol and triglycerides, in the blood. Originally developed in Germany by the pharmaceutical company Boehringer Mannheim, the brand has a long history in the cardiovascular treatment market. Over several decades, ownership changed hands through various mergers and acquisitions involving major industry players like Roche and Actavis.

Today, Bezalip is part of the extensive portfolio of Aristo Pharma, a major German pharmaceutical group that specializes in the production of high-quality generic and branded medications. While the brand remains rooted in German pharmaceutical excellence, manufacturing for various global markets often takes place across several European facilities to ensure consistent supply. The ultimate owner, Aristo Pharma GmbH, is headquartered in Berlin, Germany, and manages the distribution and marketing of the product through local subsidiaries and partners across Europe and other international regions.